idarubicin has been researched along with Obesity in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baer, MR; Barcos, M; Block, AW; Ford, LA; Hyland, AJ; Lee, HJ; Licht, AS; Sait, SN; Wang, ES; Wetzler, M | 1 |
Avvisati, G; Bagnardi, V; Breccia, M; Cimino, G; Disalvatore, D; FoĆ , R; Latagliata, R; Lo-Coco, F; Loglisci, G; Mazzarella, L; Minotti, C; Pelicci, PG; Petti, MC; Testi, AM | 1 |
Chi, M; Estey, E; Lin, A; McQuary, A; Othus, M | 1 |
Helmchen, C; Hofmann, C; Machner, B; Neppert, B; Paulsen, M; Sander, T | 1 |
4 other study(ies) available for idarubicin and Obesity
Article | Year |
---|---|
Is obesity a prognostic factor for acute myeloid leukemia outcome?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Clinical Trials, Phase I as Topic; Cytarabine; Databases, Factual; Female; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Obesity; Retrospective Studies; Treatment Outcome; Young Adult | 2012 |
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Obesity; Overweight; Prognosis; Risk Factors; Survival Rate; Syndrome; Tretinoin; Young Adult | 2012 |
Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fever; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Neutropenia; Obesity; Outcome Assessment, Health Care; Prognosis; Remission Induction; Young Adult | 2013 |
Pseudotumor cerebri as a reversible side effect of all-trans retinoic acid treatment in acute promyelocytic leukaemia.
Topics: Acetazolamide; Adult; Anticonvulsants; Antineoplastic Agents; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Obesity; Pseudotumor Cerebri; Spinal Puncture; Tretinoin | 2008 |